KA
King Andrew James
Directeur Scientifique
OtherM
Insider track record
ExecutiveNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by King Andrew James, Directeur Scientifique. Insider active across 2 companies, notably Chinook Therapeutics, INC.. In total, 16 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €29k. Activity tracked since 9 November 2021. The latest transaction was disclosed on 12 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to King Andrew James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
41,250 shares0Common StockSEC:0001193125-26-052053:0
19,157 sharesCommon StockSEC:0001209191-23-045424:0
3,333 sharesCommon StockSEC:0001209191-23-044071:0
2,500 shares@ US$0.352.0% of flowCommon StockSEC:0001209191-23-023351:0
6,803 sharesCommon StockSEC:0001209191-23-009766:0
8,333 sharesCommon StockSEC:0001209191-23-006371:0
7,500 shares@ US$0.356.2% of flowCommon StockSEC:0001209191-23-001434:0
10,152 sharesCommon StockSEC:0001209191-22-053301:0
5,000 shares@ US$0.354.3% of flowCommon StockSEC:0001209191-22-044596:0
5,000 shares@ US$0.354.4% of flowCommon StockSEC:0001209191-22-042041:0
5,000 shares@ US$0.354.2% of flowCommon StockSEC:0001209191-22-024324:0
2,500 shares@ US$13.0074.4% of flowCommon StockSEC:0001209191-22-012315:0
6,801 sharesCommon StockSEC:0001209191-22-009564:0
2,500 shares@ US$0.352.0% of flowCommon StockSEC:0001209191-22-008937:0
2,500 shares@ US$0.352.0% of flowCommon StockSEC:0001209191-21-064363:0
10,151 sharesCommon StockSEC:0001209191-21-060112:0
About King Andrew James
King Andrew James is Chief Scientific Officer. The declarant has 16 filings in total, and across the recent filings available from 2021-10-08 to 2026-02-13, sales total EUR 28593 and purchases EUR 0, with Levée d'options being the most frequent transaction type.